Other Therapy Areas

Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.

Learn More →

    Home > why-veristat company/about approach veristat-press-coverage corporate-responsibility news events global-reach-locations therapeutic-expertise Therapeutic areas > therapeutic-expertise/oncology therapeutic-expertise/neurology endocrine-metabolic-disease therapeutic-expertise/immunology-and-inflammation therapeutic-expertise/infectious-disease therapeutic-expertise/covid-19 therapeutic-expertise/cardiology therapeutic-expertise/other solutions full-service-cro-biologics cro-cell-gene therapeutic-expertise/rare-diseases therapeutic-expertise/pediatric-clinical-trials decentralizedclinicaltrials services/full-service-solutions clinical-trial-planning clinical-trial-conduct regulatory-submission solutions/natural-history-studies services regulatory-writing-services-old services/strategic-consulting services/introduction-statistical-power services/regulatory-affairs-overview services/regulatory-affairs/regulatory-approvals services/chemistry-manufacturing-controls-cmc services/regulatory-affairs/regulatory-agency-meeting-support services/regulatory-affairs/regulatory-publishing services/clinical-operations services/clinical-operations/monitoring patient-recruitment-for-clinical-trials patient-retention-and-site-engagement medical-affairs-overview services/medical-affairs/medical-monitoring-for-clinical-trials services/biometrics pharmacovigilance quality-assurance-and-compliance services/strategic-resourcing library blog latest-newsletter contact-us rfp covid-19 COVID-19

    Therapeutic Areas/Infectious Disease

    COVID-19

    Accelerating the rapid launch of COVID-19 vaccine and treatment trials with confidence. 

    While the COVID-19 pandemic has transitioned to its endemic stage, the need for developing new vaccines, boosters and treatments continues.  Get started with bold scientific thinking from the clinical and regulatory teams that supported more than 70 COVID-19 clinical trials and consulting projects since the start of the pandemic. 

    Our global team of experts are available to assist  with clinical trial design, clinical trial conduct, and all the regulatory and safety support required to keep your clinical development programs on track.  And we offer proven virtual or decentralized trial solutions to ease the burden of patient participation.   

    Developing a COVID-19 treatment or vaccine? 

    Submit Your RFP     Contact Our Experts

    +0

    COVID-19 Clinical Trials and Consulting Projects

    +0

    IND/CTAs prepared

    0%

    for COVID-19 Vaccines

    Supporting COVID-19 Vaccine, Diagnostic, and Treatment Programs

    Home > why-veristat company/about approach veristat-press-coverage corporate-responsibility news events global-reach-locations therapeutic-expertise Therapeutic areas > therapeutic-expertise/oncology therapeutic-expertise/neurology endocrine-metabolic-disease therapeutic-expertise/immunology-and-inflammation therapeutic-expertise/infectious-disease therapeutic-expertise/covid-19 therapeutic-expertise/cardiology therapeutic-expertise/other solutions full-service-cro-biologics cro-cell-gene therapeutic-expertise/rare-diseases therapeutic-expertise/pediatric-clinical-trials decentralizedclinicaltrials services/full-service-solutions clinical-trial-planning clinical-trial-conduct regulatory-submission solutions/natural-history-studies services regulatory-writing-services-old services/strategic-consulting services/introduction-statistical-power services/regulatory-affairs-overview services/regulatory-affairs/regulatory-approvals services/chemistry-manufacturing-controls-cmc services/regulatory-affairs/regulatory-agency-meeting-support services/regulatory-affairs/regulatory-publishing services/clinical-operations services/clinical-operations/monitoring patient-recruitment-for-clinical-trials patient-retention-and-site-engagement medical-affairs-overview services/medical-affairs/medical-monitoring-for-clinical-trials services/biometrics pharmacovigilance quality-assurance-and-compliance services/strategic-resourcing library blog latest-newsletter contact-us rfp covid-19 COVID-19
    • Let's Talk.
      Contact Veristat Today!

      We know there are always unknown challenges when bringing a novel therapeutics to market, so we’ve  assembled an extraordinary team of scientific minded experts who have mastered the complexities of therapeutic development enabling sponsors to succeed in extending and saving lives.

    News:  Congratulations on COVID-19 Vaccine Approval

    Veristat study collaboration with HIPRA leads to EMA approval of BIMERVAX® COVID-19 vaccine, the first bivalent recombinant protein vaccine to be authorized in the EU and the first human health vaccine to be designed and developed in Spain.

     READ PRESS RELEASE

    Home > why-veristat company/about approach veristat-press-coverage corporate-responsibility news events global-reach-locations therapeutic-expertise Therapeutic areas > therapeutic-expertise/oncology therapeutic-expertise/neurology endocrine-metabolic-disease therapeutic-expertise/immunology-and-inflammation therapeutic-expertise/infectious-disease therapeutic-expertise/covid-19 therapeutic-expertise/cardiology therapeutic-expertise/other solutions full-service-cro-biologics cro-cell-gene therapeutic-expertise/rare-diseases therapeutic-expertise/pediatric-clinical-trials decentralizedclinicaltrials services/full-service-solutions clinical-trial-planning clinical-trial-conduct regulatory-submission solutions/natural-history-studies services regulatory-writing-services-old services/strategic-consulting services/introduction-statistical-power services/regulatory-affairs-overview services/regulatory-affairs/regulatory-approvals services/chemistry-manufacturing-controls-cmc services/regulatory-affairs/regulatory-agency-meeting-support services/regulatory-affairs/regulatory-publishing services/clinical-operations services/clinical-operations/monitoring patient-recruitment-for-clinical-trials patient-retention-and-site-engagement medical-affairs-overview services/medical-affairs/medical-monitoring-for-clinical-trials services/biometrics pharmacovigilance quality-assurance-and-compliance services/strategic-resourcing library blog latest-newsletter contact-us rfp covid-19 COVID-19

    Scientific Knowledge across a Broad Range of COVID-19 Therapies

    COVID-19 Prevention

    • Antiseptic Nasal Sprays 
      Vaccines- DNA 
      Vaccines- mRNA 
      Vaccines- Peptide 
      And more... 
    therapeutic_vaccine_image11

    COVID-19 Treatments 

    • Anti-Inflammatories 
      Anti-virals 
      Cannabinoids 
      Monoclonal Antibodies 
      And more... 
    therapeutic_image15
    "We thank the entire Veristat team, who has worked so diligently. We are gratified to know that the efforts and commitment of Verisat has resulted in an approved vaccine to advance protection against the virus.”
    Spokesperson
    SPANISH PHARMACEUTICAL COMPANY

    Learn More with These Resources

    Infographic

    A Practical Guide for Managing Multiple Global Regulatory ...

    Infographic

    FDA Expedited Programs – What You Need to Know

    Fact Sheet

    Side-by-Side Comparison: Non-Adaptive vs. Adaptive Designs in ...